Phase1b/2 Trial Of AZA + APG1252 In Patients With High-Risk AML
Phase1b/2 Trial Of AZA + APG1252 In Patients With High-Risk AML
Recruiting · NCT07508982 · Registry updated 2026-10-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase1b/2 Trial Of AZA + APG1252 In Patients With High-Risk AML | acute myeloid leukemia | Recruiting | Phase 1 / Phase 2 | 2026-10-05 | NCT07508982 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| M.D. Anderson Cancer Center | 1145 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| UT MD Anderson | Houston | United States | 34 |